Key facts
- This page summarizes Rachel K. King's Form 4 filing for GLYCOMIMETICS INC (GLYC).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 02 Apr 2024, 16:05.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Award
No transaction description listed
No transaction description listed
No transaction description listed
Additional SEC filing notes
Footnote F1
These shares will be issued to the reporting person pursuant to the issuer's non-employee director compensation policy in lieu of board and committee retainer fees of $10,000.
Footnote F2
The reporting person is co-manager of this entity. She disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein.
Footnote F3
These shares are held by family trusts, for which Ms. King serves as trustee, as follows: 1,741 shares are held by The Langley C. King 1990 Trust, 8,796 shares are held by the 1995 Connor A. King Trust, 8,796 shares are held by the 1995 Langley C. King Trust, 23,301 shares are held by The Connor King 2013 GRAT, 23,301 shares are held by The Langley C. King 2013 GRAT and 24,725 shares are held by The Rachel K. King 2016 GRAT. The total amount excludes 1,741 shares that were previously held by the Connor A. King 1988 Trust, as the trust has terminated and the shares are not beneficially owned by the reporting person.